Metagenomi Therapeutics MGX
NASDAQ MGX
$1.10 -0.03 (-3.11%)
As of: Sep 30, 2026 · 1:32 PM EDT

Metagenomi Therapeutics, Inc. (MGX) Current Assets (2023 - 2026)

Updated

Metagenomi Therapeutics (MGX) recorded Current Assets of $124.47 million in Q2 2026, down 41.2% from $211.68 million a year earlier and down 13.9% from the prior quarter.

Analysis

Metagenomi Therapeutics, Inc. (MGX) Current Assets (2023 - 2026) Analysis & Trends

At the end of FY2025, Metagenomi Therapeutics reported Current Assets of $165.54 million, down 35.8% from FY2024.

  • Across earlier years, Current Assets came in at $257.96 million in FY2024 (-7.3%) and $278.27 million in FY2023.
  • The Q2 2026 figure is the lowest quarterly Current Assets in data going back to Q4 2023.
  • On a year-over-year basis, Current Assets has declined for seven consecutive quarters, with an average decline of 31.0% over the last seven quarters.
  • Per Business Quant, the preceding three quarters came in at $144.56 million (Q1 2026), $165.54 million (Q4 2025) and $189.82 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 124.47 Mn
Mar 31, 2026 144.56 Mn
Dec 31, 2025 165.54 Mn
Sep 30, 2025 189.82 Mn
Jun 30, 2025 211.68 Mn
Mar 31, 2025 233.20 Mn
Dec 31, 2024 257.96 Mn
Sep 30, 2024 282.29 Mn
Jun 30, 2024 307.58 Mn
Mar 31, 2024 335.64 Mn
Dec 31, 2023 278.27 Mn
API Access

Metagenomi Therapeutics, Inc. Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=MGX&period=max&api_key=YOUR_API_KEY